14 Followers on Owler

Vivo Capital Investments

Vivo Capital has invested in 101 companies and its latest investment was Bonum on Nov 14, 2022

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Bonum is a Washington-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$93M
Nov 14, 2022
-
Zenas is a Massachusetts-based biopharmaceutical company that researches and develops immuno-therapeutics for the treatment of autoimmune and rare diseases.
$118M
Nov 06, 2022
-
Neocis is a Florida-based medical device company that manufactures and distributes robotic medical systems for the treatment of dental implant surgical applications.
$40M
Oct 26, 2022
-
VectivBio is a Switzerland-based biotechnology company that researches and develops novel therapeutics for the treatment of rare diseases.
$125M
Oct 12, 2022
-
Ventyx is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune and inflammatory diseases.
$176.6M
Sep 19, 2022
-

Frequently Asked Questions about Vivo Capital

  1. What is Vivo Capital investing in?

    Vivo Capital has invested in 101 companies including Bonum, Zenas and Yomi
  2. What company did Vivo Capital invest in?

    Vivo Capital invested in a total 101 companies including Bonum, Zenas and Yomi
  1. What are the top 5 investments by Vivo Capital?

    The top companies in which Vivo Capital invested are Bonum, Zenas, Yomi, VectivBio and Ventyx